Avalo Therapeutics (AVTX) 10-K/A 2018 FY Annual report (amended)

Exhibit 31.1

CERTIFICATION

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Joseph M. Miller, certify that:

1. I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Cerecor Inc.; and

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Date: April 23, 2019	/s/ Joseph M. Miller
	Joseph M. Miller Chief Financial Officer (Registrant’s Principal Executive Officer and Principal Financial Officer)